Search
for

    Sort by

    Research 61–90 of 1000+

    1. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    2. Patients with a large prostate show a higher prevalence of androgenetic alopecia Archives of Dermatological Research · 2005
    3. Abiraterone and spironolactone in prostate cancer: a combination to avoid Acta Clinica Belgica · 2018 · 9 citations
    4. Prostate cancer update: 2007 Current Opinion in Oncology · 2008 · 6 citations
    5. Prostate Carcinoma, what would be the best to do ? International Journal of Clinical and Medical Education Research · 2023
    6. Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient Diabetes Therapy · 2022
    7. S5 IS THE RADICAL PROSTATECTOMY THE BEST CHOICE FOR PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER? European Urology Supplements · 2010
    8. IMPLICAÇÕES DA TOMA CRÓNICA DA FINASTERIDE PARA A ALOPÉCIA ANDROGENÉTICA NO CARCINOMA DA PRÓSTATA Zenodo (CERN European Organization for Nuclear Research) · 2023
    9. UP-02.010 Urinary PSA: Marker of Benign Prostatic Hyperplasia? Urology · 2011
    10. One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital Indian journal of health sciences and biomedical research KLEU · 2017
    11. Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States 2016 · 4 citations
    12. Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss? Nature Clinical Practice Urology · 2007
    13. 피나스테라이드의 특성에 대한 이론적 연구 한국산업융합학회 논문집 · 2013
    14. 토마토 추출액 복합체가 전립선 암 세포와 전립선 비대증에 미치는 영향 생약학회지 · 2007
    15. African Journal of Biomedical Research 2025
    16. Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359 The Prostate · 1999 · 41 citations
    17. Finasteride: The First 5α-Reductase Inhibitor Pharmacotherapy · 1993 · 23 citations
    18. Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients European Urology Supplements · 2003 · 12 citations
    19. Economic Issues in the Treatment of BPH European Urology Supplements · 2006 · 11 citations
    20. Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359 The Prostate · 1999 · 3 citations
    21. 복분자 미숙과 추출물이 전립선암 세포주와 전립선비대 백서모델에 미치는 영향 Journal of the Korean Society of Food Science and Nutrition · 2014 · 1 citations
    22. Editorial Comment Urology · 2008 · 1 citations
    23. Editorial comment The Journal of Urology · 2005 · 1 citations
    24. The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis World Journal of Urology · 2026
    25. 테스토스테론으로 유도된 전립선 비대증에 대한 Sapium rotundifolium Hemsl. 추출물의 효과 KMOU Repository (Korea Maritime and Ocean University) · 2019
    26. 5ARI and PSA: open questions Urologia Journal · 2014
    27. Glatze in jungen Jahren könnte Risikofaktor für BPH sein Uro-News · 2012
    28. NEURONAL MIMICRY AS A RESISTANCE PHENOTYPE IN CANCER CELLS The Journal of Urology · 2009
    29. CAN PATIENTS WITH LUTS AND BPH DISCERN CHANGES IN PEAK URINARY FLOW RATE AND DO SUCH CHANGES CONTRIBUTE TO OVERALL SATISFACTION WITH TREATMENT? The Journal of Urology · 2009
    30. The influence of secoisolariciresinol diglusoside on non-emasculated rat in BPH Journal of Jilin Medical College · 2009